Post-effective amendment to a registration statement that is not immediately effective upon filing

Fair Value Measurements and Hierarchy (Tables)

v3.22.2.2
Fair Value Measurements and Hierarchy (Tables)
6 Months Ended 11 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 02, 2021
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Schedule of changes in the fair value  

Private

Warrant 

    

Placement

    

Public

    

Liabilities

Fair value as of January 1, 2021

$

$

$

Initial measurement on February 12, 2021 (including over-allotment)

 

280,875

 

10,857,917

 

11,138,792

Change in valuation inputs or other assumptions

$

71,550

$

2,002,917

$

2,074,467

Fair value as of December 2, 2021

$

352,425

$

12,860,834

$

13,213,259

 
P3 Health Partners Inc.      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Schedule of carrying amounts of financial instruments

    

Successor

    

June 30, 2022

    

December 31, 2021

Financial assets:

 

  

 

  

Cash

$

63,145,379

$

140,477,586

Restricted cash

 

753,920

 

356,286

Clinics fees and insurance receivables, net

 

1,931,291

 

1,090,104

Other receivables

 

261,935

 

726,903

Financial liabilities:

 

  

 

  

Accounts payable and accrued expenses

 

20,693,070

 

17,730,683

Warrants liabilities

 

5,429,009

 

11,382,826

 

Successor

Predecessor

December 31, 

December 31, 

    

2021

  

  

2020

Financial Assets:

 

  

 

  

Cash

$

140,477,586

$

36,261,104

Restricted Cash

$

356,286

$

3,641,843

Clinics Fees and Insurance Receivables, Net

$

1,090,104

$

675,954

Other Receivables

$

726,903

$

146,117

Financial Liabilities:

 

  

 

  

Accounts Payable and Accrued Expenses

$

17,730,683

$

11,793,125

Liability for Warrants

$

11,382,826

$

6,316,605

Schedule of fair value hierarchy for financial liabilities

    

Level 1

    

Level 2

    

Level 3

    

Total

Warrant liability as of June 30, 2022

$

5,270,834

$

$

158,175

$

5,429,009

Warrant liability as of December 31, 2021

 

10,880,550

 

 

502,276

 

11,382,826

   
Summary of Level 3 inputs into option pricing model

The key Level 3 inputs into the option pricing model as of June 30, 2022 relating to the Private Placement Warrants to purchase Class A Common Stock were as follows:

Volatility

    

65.00

%

Risk-Free Interest rate

 

3.00

%

Exercise Price

$

11.50

Expected Term

 

4.4

Years

The key Level 3 inputs into the option pricing model as of December 31, 2021 relating to the Private Placement Warrants to purchase Class A Common Stock were as follows:

Volatility

    

60.00

%

Risk-Free Interest rate

 

1.26

%

Exercise Price

$

11.50

Expected Term

 

4.9

Years

   
Schedule of changes in the fair value

Successor

Predecessor

    

Six Months Ended June

  

  

Six Months Ended June

30, 2022

30, 2021

Beginning Balance of Private Warrant Liability

$

502,276

$

6,316,605

Mark-to-Market Adjustment for Stock Warrants

 

(344,101)

 

10,661,579

Ending Balance of Private Warrant Liability

$

158,175

$

16,978,184

 

    

Successor

 

  

Predecessor

   

December 3, 2021

  

  

    

through

Year

December 31,

January 1, 2021

Ended

2021

through

December

(Private

December 2, 2021

31, 2020

Placement

(Class D

(Class D

Warrants)

Warrants)

Warrants)

Beginning Balance

$

793,650

$

6,316,605

$

N/A

Issuance of Class D Warrants

6,316,605

Mark-to-Market Adjustment for Stock Warrants

 

(291,374)

 

7,664,869

 

Ending Balance

$

502,276

$

13,981,474

$

6,316,605